Method and application of regulating muscle-specific promoter activity of porcine GRB10 gene

By regulating the binding of the transcription factor KLF15 and the muscle-specific promoter of the pig GRB10 gene, the problem of unknown mechanism of action of KLF15 in pigs is solved, and the muscle mass is enhanced and meat quality is improved, providing a new method for treating muscle depletion diseases.

CN118516362BActive Publication Date: 2024-11-05HAINAN RES INST OF ZHEJIANG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410968822.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-05
Estimated Expiration
2044-07-19

AI Technical Summary

Technical Problem

In economic animals such as pigs, the mechanism of KLF15 regulating the muscle-specific promoter of the pig GRB10 gene is unknown, which affects the application potential of muscle growth and meat quality improvement.

Method used

By regulating the binding of the transcription factor KLF15 to the GRB10 muscle-specific promoter, PCR amplification, vector double-enzyme digestion, cell transformation and plasmid transfection were used to enhance the activity of the muscle-specific promoter of the pig GRB10 gene.

Benefits of technology

It has achieved the realization of increasing pig muscle mass and improving meat quality, providing new therapies for the treatment of muscle depletion diseases, and providing an important theoretical basis for scientific research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118516362B_ABST
    Figure CN118516362B_ABST
Patent Text Reader

Abstract

The present invention discloses a method for regulating the muscle-specific promoter activity of the pig GRB10 gene and its application. The method controls the muscle-specific promoter activity in the pig GRB10 gene by regulating the transcription factor KLF15. The method of the present invention can be used to increase the muscle mass and improve the meat quality of pigs. The present invention studies the action mechanism of KLF15 in regulating the muscle-specific promoter activity of the pig GRB10 gene, which has important theoretical value and broad market prospects for scientific research and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of molecular biology and genetic engineering, in particular to a method for controlling muscle-specific promoter activity in pig GRB10 gene by regulating transcription factor KLF15, and application of the method in improving meat production. Background Art

[0002] Muscle-specific promoters are DNA sequences that control gene expression primarily in muscle cells. These promoters are extremely important for targeted studies and manipulation of gene expression in muscle tissue, especially for applications in muscle growth, disease treatment, and meat quality improvement. This type of promoter includes the MCK (creatine kinase) promoter and the MyoD family of transcription factors, which have been extensively studied for muscle cell differentiation and metabolism.

[0003] KLF15 (Kruppel-like factor 15) belongs to the Krüppel-like transcription factor family, and members of this family play an important role in cell metabolism, growth regulation, and disease models. Especially in heart disease and metabolic diseases, the expression regulation of KLF15 is closely related to the disease process. In addition, KLF15 also shows a regulatory role in muscle growth and differentiation, and indirectly participates in the development and repair of muscle tissue by affecting the metabolic pathways of muscle cells and the expression of growth factors.

[0004] GRB10 (Growth factor receptor-bound protein 10) is an adaptor protein that regulates growth factor signaling and is also critical in muscle development and metabolic regulation. It mainly affects cell growth and differentiation by regulating insulin signaling and IGF signaling pathways, and its expression variation in animal models is directly related to muscle growth rate and muscle quality.

[0005] Although the functions of KLF15 and GRB10 have been widely studied in model animals, their mechanisms of action and practical applications in economic animals such as pigs remain unclear. In particular, the mechanism of action of KLF15 in regulating the muscle-specific promoter activity of the pig GRB10 gene has important theoretical value and broad market prospects for scientific research and application. Summary of the invention

[0006] In order to solve the above problems, the present invention provides a method for controlling the muscle-specific promoter activity in the pig GRB10 gene by regulating the transcription factor KLF15. The method of the present invention can be used to increase the muscle mass and improve the meat quality of pigs, or to develop new therapies for treating muscle wasting diseases.

[0007] In order to achieve the above object, the present invention adopts the following technical solutions:

[0008] The invention provides a method for regulating the activity of a muscle-specific promoter in a pig GRB10 gene, wherein the transcription factor KLF15 is combined with the GRB10 muscle-specific promoter.

[0009] As a preferred embodiment of the present invention, the binding sequence of transcription factor KLF15 is shown as SEQ ID NO.1.

[0010] As a preferred embodiment of the present invention, the method comprises the following steps:

[0011] 1) Perform PCR amplification of the target gene. After successful PCR amplification of the target fragment, use a DNA gel recovery kit to recover the target DNA fragment;

[0012] 2) The recovered DNA fragments are subjected to double restriction digestion of the vector to obtain the target DNA fragment;

[0013] 3) Connect the target fragment to the vector to obtain a connection product;

[0014] 4) The ligation product is transformed into competent cells;

[0015] 5) Perform PCR to identify positive transformants, and use a plasmid extraction kit to extract positive clones that have been verified to be correct by sequencing to obtain plasmids;

[0016] 6) Transfect the plasmid into 293T cells to obtain the recombinant plasmid, which is then transferred into muscle cells.

[0017] The present invention provides a vector obtained by the above method.

[0018] The present invention provides a recombinant plasmid obtained by the above method.

[0019] The present invention also provides application of the above method in enhancing promoter transcription activity in muscle cells.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] 1) The present invention studies the mechanism of action of KLF15 in regulating the muscle-specific promoter activity of the porcine GRB10 gene, which has important theoretical value and broad market prospects for scientific research and application.

[0022] 2) The present invention provides a method for enhancing the muscle-specific promoter activity of the porcine GRB10 gene by KLF15, which can be used to increase the muscle mass and improve the meat quality of pigs, or to develop new therapies for treating muscle wasting diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1:The transcription level of GRB10 gene in different varieties, different developmental stages and different tissues.

[0024] Figure 2 : Enrichment peaks of H3K4me3 protein on the GRB10 promoter in different tissues.

[0025] Figure 3 : Scatter plot of motif prediction and gene expression difference in GRB10 promoter.

[0026] Figure 4 : Schematic diagram of primer design for CHIP experiment.

[0027] Figure 5 : PCR electrophoresis diagram of CHIP experiment and histogram of CHIP-qPCR.

[0028] Figure 6 : Dual-luciferase activity of 293T cells after transfection with different vectors.

[0029] Figure 7 : The GRB10 promoter (WT) vector map used in the present invention.

[0030] Figure 8 : The GRB10 point mutation promoter (MUT) vector map used in the present invention.

[0031] Fig. 9 : The KLF15 (KLF15) vector map used in the present invention. DETAILED DESCRIPTION

[0032] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] Example 1

[0034] This example shows the spatiotemporal transcriptional characteristics of the GRB10 gene.

[0035] Materials: Multi-tissue RNA-seq data of Meishan pigs and Yorkshire pigs.

[0036] Methods: Salmon software was used to quantify the FASTQ data of RNA-seq, and ClusterGVis software was used to cluster and visualize the quantitative data.

[0037] Results Figure 1, (1) GRB10 gene transcription is muscle tissue specific. GRB10 gene is highly expressed in muscle tissue and less expressed in other tissues.

[0038] (2) The transcription of the GRB10 gene has developmental characteristics. The expression level of the GRB10 gene increases significantly with the increase of age.

[0039] (3) The transcription of GRB10 gene has breed characteristics. The expression level of GRB10 gene in Yorkshire pigs is significantly higher than that in Meishan pigs.

[0040] (4) The two transcripts of GRB10, RNA46521 and RNA46522, have similar expression characteristics to the GRB10 gene.

[0041] Example 2

[0042] This example provides the identification of the muscle tissue-specific promoter of the GRB10 gene

[0043] Materials: Pig multi-tissue CHIP-seq data, reference genome Sscrofa11.1.

[0044] Methods: Tissue cross-linking: Take 1g of fresh muscle tissue, cut it into pieces and put it into a suction bottle, add 30ml of formaldehyde fixative, soak at room temperature for 3min, connect to a vacuum machine, vacuum for 2min, put in gas; vacuum for 1min, put in gas; vacuum for 1min, put in gas; soak at room temperature for 2min, add 2M glycine solution to a final concentration of 0.125M. The cross-linked samples were ultrasonically treated: high power, ultrasonic for 30s, interval for 20s, 30 cycles, to produce DNA fragments of 150-900 bp in size, and H3K4me3 antibodies were used to capture the target protein and its bound DNA fragments. Subsequently, the antibody-protein-DNA complex was eluted and heated at 65℃ for 4h to reverse the cross-linking and release the DNA fragments. Finally, the DNA was purified for high-throughput sequencing. The sequencing data quality was filtered using trim_galore software to eliminate low-quality data. The data after quality control were aligned to the reference genome using bowtie2 software, and then deduplicated using gatkMarkDuplicates software, and finally peak called using macs software.

[0045] Results Figure 2 A muscle-specific H3K4me3 enrichment peak was identified in the GRB10 gene, which only appeared in muscle tissue and was almost zero in other tissues. According to annotation, this segment (chr9:136626200-136628800) has strong promoter signal characteristics.

[0046] Example 3

[0047] This example provides the motif prediction of the GRB10 tissue-specific promoter

[0048] Materials: GRB10 tissue-specific promoter sequences, RNA-seq data.

[0049] Methods: FIMO software was used to predict the motif sites in the tissue-specific promoter region of GRB10. Salmon software was used to quantify the FASTQ data of RNA-seq.

[0050] Results Figure 3 , considering the p-value of motif prediction and the p-value of gene expression difference, KLF15 was considered to be the transcription factor most likely to bind to the promoter region of GRB10.

[0051] Predicted transcription factor binding sites: chr9:136627722-chr9:136627757;

[0052] The binding sequence is: SEQ ID NO.1: TTCCACCCTTGCCCCCCCCCCCACCAGCAGCACCAG.

[0053] Example 4

[0054] This example provides experimental verification of KLF15 binding to the GRB10 tissue-specific promoter

[0055] Materials: Muscle tissues of Tunchang pigs and Wai Sanyuan pigs, KLF15 antibody (Abcam ab2647), CHIP AssayKit (Biyuntian P2078), DNA purification kit (Biyuntian D0033).

[0056] method:

[0057] (1) Tissue cross-linking: Take 1g of fresh muscle tissue, cut it into pieces and put it into a suction filtration bottle, add 30ml of formaldehyde fixative, soak at room temperature for 3min, connect to a vacuum machine, evacuate for 2min, and add gas; evacuate for 1min, and add gas; evacuate for 1min, and add gas; soak at room temperature for 2min, add 2M glycine solution to a final concentration of 0.125M;

[0058] (2) Ultrasonic treatment of the cross-linked samples: high power, 30 seconds of ultrasound, 20 seconds of interval, 30 cycles, to produce DNA fragments of 150-900 bp in size;

[0059] (3) Use KLF15 antibody to capture the target protein and its bound DNA fragments;

[0060] (4) The antibody-protein-DNA complex was eluted and heated at 65°C for 4 h to reverse the cross-linking and release the DNA fragments;

[0061] (5) Purify the DNA product using a DNA purification kit;

[0062] (6) PCR amplification of the target gene sequence (reaction system see Table 1), amplification conditions: 95°C pre-denaturation for 2 min, 30 cycles of 95°C denaturation for 20 sec, 60°C annealing for 20 sec, 72°C extension for 15 min, and finally 72°C extension for 2 min. The amplified product was detected by 1% agarose gel electrophoresis;

[0063] Table 1 PCR reaction system

[0064]

[0065] (7) qPCR detection of the relative expression level of the target gene.

[0066] Primers: The forward primer sequence is SEQ ID NO.2: 5'-AAGCAGCAGCATCTCATC-3', and the reverse primer sequence is SEQ ID NO.3: 5'-TCTCAACTTCTGTCACCTTC-3'. The forward and reverse primers are not limited thereto, and primers can be designed in the regions on both sides of the chr9:136627722 to chr9:136627757 sites.

[0067] Results Figure 4 and Figure 5 KLF15 can bind to the GRB10 tissue-specific promoter, and the enrichment level of KLF15 on the GRB10 promoter in Tunchang pigs is significantly higher than that in foreign three-way pigs.

[0068] Example 6

[0069] This example shows that KLF15 regulates the activity of the GRB10 tissue-specific promoter

[0070] Experimental materials: restriction endonuclease (Thermo Scientific), micro agarose gel DNA recovery kit (Shengang B518131-0100), plasmid extraction kit (Shengang B518191-0050), PrimeSTAR Max Premix (2X) (Takara R045A), TaKaRa Taq (Takara R001B), ClonExpress II One Step CloningKit ligase (Novozyme C112-2), BL21 competent cells (Huijun Biotechnology), pGL3-Basic vector, 293T cells, DMEM medium, trypsin (Gibco, catalog number: 25200-072), serum (Excell), transfection reagent FItran (Huijun Biotechnology, catalog number: FA1802), high-sensitivity tube luminescence detector (Guangzhou Bolu Teng Biotechnology Co., Ltd., Lux-T020), Dual-Luciferase®Reporter Assay System (Promega, E1910).

[0071] GRB10 promoter (WT) vector map Figure 7 As shown, the GRB10 point mutation promoter (MUT) vector map is as follows Figure 8 As shown, the KLF15 (KLF15) vector map is as follows Fig. 9 shown.

[0072] method:

[0073] (1) Construction of reporter gene vector:

[0074] PCR amplification of GRB10 promoter (WT) and GRB10 point mutation promoter (MUT). The PCR amplification system is: 50ng plasmid template, 0.2μL upstream primer, 0.2μL downstream primer, 5μL PrimeSTAR Max (2×), add deionized water to 10μL. Amplification conditions: 95℃ pre-denaturation for 5min, 30 cycles of 95℃ denaturation for 20sec, 60℃ annealing for 30sec, 72℃ extension for 1min, and finally 72℃ extension for 3min. After the target fragment is successfully amplified by PCR, it is detected by 1% agarose gel electrophoresis. By comparing with DNA marker, it is determined whether the amplification is successful, and then the DNA target fragment is recovered using a DNA gel recovery kit. The primers are designed as follows:

[0075] WT-F (SEQ ID NO. 4): TTACGCGTGCTAGCCCGGGCTCGAGCCAGGCCCTCCACCCGAT;

[0076] WT-R (SEQ ID NO. 5): AGTACCGGAATGCCAAGCTTTGTCGTCAGCTGTGTGCCC;

[0077] MUT-F (SEQ ID NO.6):CCCACCAGAGAACAAGATAAACGGGGGAAGG;

[0078] MUT-R (SEQ ID NO.7): ATCTTGTTCTCTGGTGGGGCATGAGCAG;

[0079] The recovered DNA fragments were double-digested with the vector. The digestion system was: 3 μL 10× Buffer, 5 μg pcDNA3.1(+) vector (such as Figure 7 As shown), 1.5 μL NotI, 1.5 μL HindIII, add deionized water to 30 μL. Digest at 37℃ for 60 min. After the vector digestion, perform 1% agarose gel electrophoresis and recover the target DNA fragment according to the experimental steps of the DNA gel recovery kit.

[0080] Ligate the target fragment to the pGL3-Basic vector. The specific reaction system is: (0.02x the number of base pairs of the vector) ng of the vector recovered by restriction digestion, (0.04x the number of base pairs of the insert) ng of the product recovered by PCR, 2μL 5×CE II Buffer, 1μL Express® II, and add deionized water to make up to 10μL. Ligate at 37℃ for 30min and ice bath for 5min.

[0081] The dual-luciferase reporter gene plasmids of GRB10 promoter (WT) and GRB10 point mutation promoter (MUT) were obtained.

[0082] (2) Construction of KLF15 expression vector:

[0083] The complete cDNA sequence of the KLF15 gene was cloned by PCR. The PCR amplification system was: 50 ng plasmid template, 0.2 μL upstream primer, 0.2 μL downstream primer, 5 μL PrimeSTAR Max (2×), and deionized water was added to make up to 10 μL. Amplification conditions: 95°C pre-denaturation for 5 min, 30 cycles of 95°C denaturation for 20 sec, 60°C annealing for 30 sec, 72°C extension for 1 min, and finally 72°C extension for 3 min. After the target fragment was successfully amplified by PCR, it was detected by 1% agarose gel electrophoresis. By comparing with the DNA marker, it was determined whether the amplification was successful, and then the DNA target fragment was recovered using a DNA gel recovery kit. The primers were designed as follows:

[0084] KLF15-F (SEQ ID NO. 8): GGCTACGTTTAAACTTAAGCTTATGTCGGAGGAGCAAGGTA;

[0085] KLF15-R (SEQ ID NO. 9):TCTAGACTCGAGCGGCCGCTCAGGGGCGCGCAGCGCG.

[0086] The recovered DNA fragments were double-digested with the vector. The digestion system was: 3 μL 10× Buffer, 5 μg pcDNA3.1(+) vector (such as Figure 7 As shown), 1.5 μL NotI, 1.5 μL HindIII, add deionized water to 30 μL. Digest at 37℃ for 60 min. After the vector digestion, perform 1% agarose gel electrophoresis and recover the target DNA fragment according to the experimental steps of the DNA gel recovery kit.

[0087] The target fragment was connected to the pcDNA3.1(+) vector. The specific reaction system is: (0.02x the number of base pairs of the vector) ng of the vector recovered by restriction digestion, (0.04x the number of base pairs of the insert fragment) ng of the product recovered by PCR, 2μL 5×CE II Buffer, 1μL Express®II, and deionized water was added to make up to 10μL. The connection was carried out at 37℃ for 30min and then iced for 5min.

[0088] (3) Cell culture and transfection:

[0089] Transform the obtained plasmid into DH5α competent cells: Add 10μL of the ligation product to 100μL of DH5α competent cells in an ice bath. Gently rotate to mix and ice bath for 30min. Heat shock in a 42℃ water bath for 60s. Then quickly transfer the tube to an ice bath and ice bath for 2-3min. Spread the bacterial solution evenly on an LB plate containing Amp antibiotic (100μg / mL) and culture at 37℃ overnight.

[0090] PCR was performed to identify positive transformants, and a plasmid extraction kit was used to extract positive clones that were verified to be correct by sequencing.

[0091] Transfect the reporter gene vector and KLF15 expression vector into 293T cells respectively, and culture them in a CO2 incubator for 48 hours. Collect the cells and detect the activity of sea cucumber luciferase. The combination is as follows:

[0092] pGL3-basic-WT+pCDNA3.1-KLF15+pRL-TK (KLF15+wild promoter);

[0093] pGL3-basic-WT+pCDNA3.1-empty vector+pRL-TK (Control+wild promoter);

[0094] pGL3-basic-MUT+pCDNA3.1-KLF15+pRL-TK (KLF15+mutant promoter);

[0095] pGL3-basic-MUT+pCDNA3.1-empty vector+pRL-TK (Control+mutant promoter).

[0096]

[0097] The wild promoter (WT) sequence is shown in SEQ ID NO.11:

[0098]

[0099] The mutant promoter (MUT) sequence is shown in SEQ ID NO.12:

[0100]

[0101] Results: See Figure 6 , (1) The activity of the KLF15 wild-type promoter was upregulated by 71% compared with the Control wild-type promoter (p < 0.05), indicating that the KLF15 transcription factor can regulate the expression of the wild-type promoter; (2) The activity of the KLF15 mutant promoter was downregulated by 23% compared with the KLF15 wild-type promoter (p < 0.05), indicating that the mutation site is the KLF15 transcription factor binding site; (3) The activity of the KLF15 mutant promoter is still higher than that of the Control mutant promoter, indicating that the mutation site affects the activity of the promoter.

[0102] It can be seen that the method of the present invention for enhancing the muscle-specific promoter activity of the pig GRB10 gene through KLF15 can be used to increase the muscle mass and improve the meat quality of pigs, or to develop new therapies for treating muscle wasting diseases.

[0103] The above is only a preferred embodiment of the present invention, and is not any formal or substantial limitation of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and supplements without departing from the method of the present invention, and these improvements and supplements should also be regarded as the protection scope of the present invention. Any technician familiar with this profession, without departing from the spirit and scope of the present invention, can make some changes, modifications and evolutions of the technical content disclosed above, which are equivalent embodiments of the present invention; at the same time, any changes, modifications and evolutions of any equivalent changes made to the above embodiments based on the essential technology of the present invention are still within the scope of the technical solution of the present invention.

Claims

1. A MUT GRB10 promoter, characterized in that The sequence of the MUT GRB10 promoter is shown in SEQ ID NO.

12.

2. A carrier, characterized in that It comprises the MUT GRB10 promoter according to claim 1.

3. A recombinant plasmid, characterized in that: It comprises the MUT GRB10 promoter according to claim 1.